Nutex Health Inc. - Form 4 Filing

Michael Reed, a director at Nutex Health Inc., was granted 823 Restricted Stock Units (RSUs) on April 23, 2026. These RSUs vest fully on April 23, 2027. Each RSU represents a contingent right to receive one share of the company's common stock upon vesting. In the event of termination without cause, the RSUs will vest on a pro-rata basis. Following this grant, Mr. Reed holds a total of 1426 shares. The transaction is reported on Form 4, with the signature date of April 24, 2026. The filing indicates that the shares were acquired at a price of $0.00, as noted in footnote F1.